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Activation-induced cytidine deaminase (AID) is
required for immunoglobulin (Ig) gene class
switch recombination (CSR), somatic hypermu-
tation (SHM), and somatic hyperconversion. In
general, high AID expression is found in mature
B cells that are responding to antigens. How-
ever, AID expression and SHM have also been
detected in developing B cells from transgenic
mice that have a limited Ig repertoire. Here we
demonstrate thatAIDexpression, ongoingCSR,
and active SHMoccur in developingBcells from
wild-typemice. Further, our results suggest that
somatic variants arising fromdeveloping B cells
in the bonemarrow further diversify in the spleen
of unimmunized mice. AID expression in devel-
oping B cells is T cell independent but involves
engagement of B cell receptors and Toll-like re-
ceptors. Early AID expression can increase the
preimmune repertoire of developing B cells,
mayprovidean innatepopulationof IgG-and IgA-
expressing cells, and could be involved in re-
ceptor editing of self-reactive immature B cells.
INTRODUCTION
One of most critical initial steps in lymphocyte develop-
ment is the creation of a lymphocyte receptor repertoire.
This occurs by the process of V(D)J recombination as me-
diated by the recombination-activating genes, Rag1 and
Rag2 (Oettinger et al., 1990; Schatz et al., 1989). In the B
cell lineage, V(D)J recombination leads to diversification
of immunoglobulin (Ig) receptors by a random rearrange-
ment of gene segments encoding Ig during B cell develop-
ment. Further diversification is achieved by somatic hy-
permutation (SHM) (Neuberger and Milstein, 1995), which
introduces point mutations to rearranged Ig genes, or by64 Immunity 27, 64–75, July 2007 ª2007 Elsevier Inc.somatic hyperconversion (SHC), which replaces portions
of the Ig variable (V) region sequencewith pseudo V region
sequences (Reynaud et al., 1989). Additional modifica-
tion also occurs by class switch recombination (CSR), a
process that changes the Cm constant region to another
constant region gene (Cg, Ca, or C3) (Honjo et al., 1981)
to define the Fc-mediated effector functions.
SHM, CSR, and SHC require activation-induced cyti-
dine deaminase (AID). AID is expressed upon activation
of B lymphocytes, and it has been widely accepted that
CSRandSHMoccur during germinal center (GC) reactions
after antigen activation of mature B cells with T cell help
(Kelsoe, 1995; Muramatsu et al., 1999). However, some
studies have indicated that SHM may occur outside of
the GCs (Kato et al., 1998; Wang et al., 2000; William
et al., 2002), that SHM can occur without T cell help (Mon-
son et al., 2001; Toellner et al., 2002; Weller et al., 2001),
and that SHMcan occur even in the absence of an immune
response (Reynaud et al., 1995; Weller et al., 2004). The
exact mechanisms involved in T-independent SHM pro-
cesses that occur outside of the GCs are not known.
The paradigm that SHM is limited to mature B cells has
also been recently challenged by a report showing that, in
mutant mice having a limited Ig repertoire (k light-chain-
deficient and quasimonoclonal [QM] mice), SHM of l light
chain can occur in immature bone-marrow (BM) B cells
(Mao et al., 2004). This l light-chain SHM was T indepen-
dent and correlated with AID expression in the immature B
cells. However, despite detection of AID expression in
immature B cells both from the k light-chain-deficient
and QM mutant mice and from wild-type normal C57BL/
6 mice, no l light-chain SHM was found from the wild-
type C57BL/6 mice. The basis for this difference is not
known; one proposed hypothesis is that SHM events in
immature B cells occur at lower frequencies in l than in
k (Mao et al., 2004).
The expression of AID in developing B cells in both mu-
tant and normalmice (Maoet al., 2004) raises questions re-
garding the mechanism of AID induction at these early
stages of B cell development. In mature B cells, AID
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(BCR), cytokines, and the interactionbetweenBandTcells
via CD40:CD40 ligand (Armitage et al., 1992). Stimulation
of human and mouse mature B cells via Toll-like receptors
(TLRs) also can induce activation andCSR (Heet al., 2004).
Perhaps BCR or TLR signaling might be involved in AID in-
duction in developing B cells, although it is not clear which
ligands might mediate this signaling. TLRs are evolution-
arily conserved germline-encoded receptors that recog-
nize pathogen-associated molecular patterns (PAMPs)
and initiate innate immune responses. TLR signaling re-
quires a set of adaptor molecules including myeloid differ-
entiation factor 88 (MyD88), myeloid differentiation protein
88 adaptor-like (MAL), Toll and IL-1 receptor domain-con-
taining adaptor inducing interferon-b (TRIF), and TRIF-
related adaptor molecule (TRAM) to induce appropriate
gene expression. MyD88 is the most broadly used adap-
tor, essential for signaling via almost all TLRs, though
TLR3 does not depend upon MyD88 and TLR4 is only
partially dependent upon it (Kawai et al., 1999; Yamamoto
et al., 2002, 2003a, 2003b; Hoebe et al., 2003).
Bone marrow is an extremely heterogeneous microen-
vironment where a variety of biological events, such as cell
proliferation, differentiation, and death take place and
single-stranded DNA (ssDNA), double-stranded DNA
(dsDNA), RNA, or Smith and ribonucleoprotein antigens
(Sm/RNP) are released from apoptotic cells: molecules
that are sensed via TLRs3, 7, and 9. InmatureB cells, such
endogenous self-antigens can synergistically engage
BCR and TLR and activate autoreactive B cells (Lau et al.,
2005; Leadbetter et al., 2002). It is possible that such self-
antigens released from dying cells in the BM also syner-
gistically engage TLRs and self-reactive BCR to induce
activation of developing B cells. Indeed, skewing of immu-
noglobulin subtypes was observed in the serum of mice
lackingMyD88 and TRIF, in which no TLR signaling occurs
(Gavin et al., 2006). However, the role of nucleic acid sens-
ing was not specifically analyzed in this study.
To directly address the role of AID during B cell develop-
ment, we have now analyzed the expression of AID in the
BM of normal mice. The results presented here, with dem-
onstration of active CSR and SHM of Vk4, strongly indi-
cated that CSR and SHM were ongoing processes during
B cell development of normal mice and that these pro-
cesses were T cell independent. The somatic variants
generated in developing B cells appeared to migrate to
and further diversify in the spleen during the maturation
process. In addition, we present evidence that BCR and
TLR engagement were involved in the activation of devel-
oping B cells to express AID. Our results therefore suggest
that TLRs can play a crucial role in shaping the develop-
ment of the adaptive immune system.
RESULTS
Activation-Induced Cytidine Deaminase
Is Expressed in Developing B Cells of Normal Mice
To determine whether CSR and SHMmight be features of
normal BM B cell development, AID expression was mea-sured by PCR and quantitative real-time PCR (qPCR) after
reverse transcription (RT) in sorted developing B cells from
BM. As a negative control, we used sorted developing
B cells from AID-deficient (Aicda/) mice. Because
Aicda/ mice are on a mixed C57BL/6 and CBA back-
ground (Muramatsu et al., 2000), Aicda/ mice were
generated by intercrossing Aicda+/ mice. This allowed
us to use Aicda+/+ littermates with the samemixed genetic
background as the control Aicda/ mice. In addition, we
examined sorted developing B cells from the BM of
C57BL/6, BALB/c, and CBA mice.
Bone-marrow cells from three 6-week-old mice of each
strain were purified by fluorescence-activated cell sorting
(FACS) into live (propidium iodide [PI]-excluding) pro-B to
pre-B (hereafter pre-B) cells (AA4.1+B220+kl) and im-
mature B cells (AA4.1+B220+k+l+) (Figure S1A in the Sup-
plemental Data available online). AID expression was also
analyzed in sorted B cells isolated from Peyer’s patches
(PP). PPs are a good source of mature B cells undergoing
active CSR and SHM as a result of activation by commen-
sal antigens (Ehrenstein and Neuberger, 1999; Gonzalez-
Fernandez and Milstein, 1993). PP B cells were separated
into two populations by FACS: B220+IgMhi cells that rep-
resent mature naive B cells that have not undergone
CSR, and B220+IgMlo cells that are presumably undergo-
ing CSR to IgG or IgA (Figure S1B). Finally, we measured
AID expression in FACS-sorted mature B cells from the
spleen, which were defined as AA4.1B220+k+l+ (Fig-
ure S1C). The FACS staining profiles of each cell popula-
tion were almost identical in all the tested mouse strains
(data not shown).
Figure 1Ashows the expression of AIDandRAG-2,mea-
suredbyPCR, in the indicated populations of BMandPPB
lineage cells isolated from the indicated strains of mice. As
expected, RAG-2 expression is detected only in pre-B and
immature B cells, validating our cell-purification proce-
dure. Strikingly, AID expression was detected in all B line-
agepopulations obtained fromAID-sufficientmice, includ-
ing pre-B and immature B cells of the BM. AID expression
was detected by RT-PCR reactions in the sorted BM-
derived immature B cell population of normal C57BL/6
mice as previously reported (Mao et al., 2004). In addition,
expression of AID was detected in pre-B cells. Expression
of AID by pre-B and immature B cells was clearly observed
not only in C57BL/6 mice but also in age-matched (6-
week-old) BALB/c, Aicda+/+ littermate control (Figure 1A),
and CBA (Figure 1B) mice. No AID expression was seen
in any cell population isolated from Aicda/ mice.
In order to quantitatively compare the amounts of AID
mRNA expression in different cell populations, we turned
to quantitative real-time PCR (qPCR) analysis (Figures 1B
and 1C). C57BL/6 mice consistently expressed lower
amounts of AID mRNA than Aicda+/+ littermate controls,
CBA, or BALB/c mice. CBA and BALB/c mice showed
about 1.5 to 3 times higher AID mRNA expression than
C57BL/6 in pre-B and immature B cells.Aicda+/+mice dis-
played amounts of AID mRNA expression in immature B
cells intermediate between C57BL/6 and CBA (Figure 1B).
Also, the amounts of AID mRNA expression in pre-B cellsImmunity 27, 64–75, July 2007 ª2007 Elsevier Inc. 65
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TLR- and BCR-Mediated CSR and SHM in Early B CellsFigure 1. Expression of AID in Pre-B and Immature B Lymphocytes from Inbred Strains of Mice
(A) AID and RAG-2 expression were analyzed by RT-PCR in the sorted pre-B and immature B lymphocytes from BM and IgMhi and IgMlo mature B
cells from PP of C57BL/6, Aicda/, Aicda+/+, CBA, and BALB/c mice.
(B andC) The relative AID expression (B) in pre-B and immature B cells from different mouse strains and (C) of B cells in different lymphoid tissues from
wild-type (Aicda+/+) littermate controls were quantified by quantitative real-time PCR (qPCR) from the sorted cells as described in Experimental
Procedures. Consistent results were obtained by more than three repetitions of the experiments. N.D., not detected. Error bars represent standard
deviation.were consistently about 10%or less than immature B cells
across different strains when normalized by b-actin
(Figure 1B). Previously, it has been reported that about
16% of C57BL/6 immature B cells express AID by sin-
gle-cell analysis (Mao et al., 2004). This previous finding,
combined with our current quantitative analysis, indicates
that AID-expressing pre-B cells represent about 1% of the
population. Pre-B and immature B cells exhibited lower
amounts of AID mRNA expression compared to PP-de-
rived B cells (Figure 1C). Notably, naive splenic mature B
cells had lower relative AID mRNA expression than did
BM immature B cells.
AID Expression in the BM Induces Ongoing
CSR in Developing B Cells
In order to ascertain that AID expressed in pre-B and
immature B cells is active and functional, the presence
of circle transcripts (CTs) and postswitch transcripts
(PSTs) was assessed in these cells. CSR is accompanied
by deletion of circular DNA (CD) from the immunoglobulin
heavy-chain locus. Each CD contains the I-promoter,
which is still active in looped-out CD and directs produc-
tion of I-Cm transcripts termed circle transcripts (CTs)
(Kinoshita et al., 2001). CTs are produced in an AID-de-
pendent manner and disappear from B cells very rapidly.
Thus, the best demonstration of active ongoing CSR is
the presence of CTs in the cells being analyzed. In addi-66 Immunity 27, 64–75, July 2007 ª2007 Elsevier Inc.tion, after CSR takes place, the germline m promoter
becomes associated with a particular CH gene that repre-
sents the isotype, stays active, and generates Im-CH tran-
scripts termed postswitch transcripts (PSTs) (Muramatsu
et al., 2000). PCR amplification of CT cDNA was followed
by Southern blot analysis in order to enhance the sensitiv-
ity of detection. It is noteworthy that CT-a exhibit two tran-
scripts because of alternative splicing donor sites in the Ia
exon (Kinoshita et al., 2001).
CTs for IgA (CT-a) and IgG2b (CT-g2b) were clearly
detected in cDNA obtained from sorted pre-B and imma-
ture B cells from wild-type AID control (Aicda+/+), whereas
noCTsweredetected in cDNAof sortedpre-Bor immature
B cells from Aicda/ mice in vivo (Figure 2A). Im-Cm PCR
productswere usedas loading controls andweredetected
by Southern blot analysis. The distribution of the isotypes
expressed was not equal across different strains of mice.
For instance, CT-a and CT-g2b were also detected from
C57BL/6 pre-B and immature B cells (Figure 2B), whereas
CT-g2b andCT-g3were found in both pre-B and immature
B cells of BALB/c mice (Figure 2C).
To confirm that CSR led to proper recombination, we
amplified PSTs for each isotype by using specific primers
(Muramatsu et al., 2000). PSTs were found corresponding
to the expected isotypes that had been indicated by CTs,
confirming that some fractions of the sorted cells are
undergoing active CSR (Figures 2A–2C).
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TLR- and BCR-Mediated CSR and SHM in Early B CellsFigure 2. Ongoing CSR in Developing B Cells In Vivo
(A–C) CTs and PSTs for g2b, g3, and a were detected by Southern blot analyses of PCR-amplified cDNA from sorted pre-B and immature B cells in
naive (A) Aicda+/+, (B) C57BL/6, and (C) BALB/c, but not detected in naive (A) Aicda/mice. Im-Cm is shown as cDNA loading control. Positive control
samples were prepared as described in the Supplemental Data. Assays marked with asterisks (*) have identical positive controls because these were
analyzed in a single blot. Sample loadings in (B) and (C) were not normalized, and therefore variations in signal intensities may not be meaningful.
(D) Surface expression of IgAwasmeasured by FACS analyses. For this assay, 7- to 11-week-oldAicda/ orAicda+/micewere used. FACS contour
plots are shown for representative Aicda/ or Aicda+/ mice stained either with anti-IgA or with an isotype-matched control antibody.
(E) Percentages of AA4.1+B220+IgA+ or AA4.1+B220+Iso.Cotrl.+ populations determined from FACS analyses as in (D) are depicted as vertical scatter
plots. Each dot represents the percentage of the population from an individual mouse, and each mean percentage value is shown as a horizontal bar.
Five Aicda/ and ten Aicda+/ mice were tested. The p value was obtained by one-tailed Student’s t test.
(F) The BMAA4.1+B220+IgA+ population was sorted and pooled from three Aicda+/ or two Aicda/mice. cDNAwas synthesized from purified RNA,
and AID, PST-a, a-transcript, CT-a, and GAPDH were amplified by PCR. 5-fold sample dilutions are shown for Aicda+/ and Aicda/ to allow semi-
quantitative comparisons of signals within each PCR assay. Comparison of signals between PCR assays is not meaningful because of differences in
reaction efficiencies. The two CT-a panels are from the same blot; one panel is overexposed (O.E.) to increase sensitivity.To further determine whether CSR in developing B cells
led to appropriate cell-surface protein expression, we
stained BM cells from Aicda+/ and Aicda/ mice and
examined the surface expression of IgA by using FACS
analysis. Viable (PI) BM single-cell suspensions were
stained with antibodies specific for B220, AA4.1, and
IgA. Figure 2D (bottom) shows that a fraction of BMB cells
from Aicda+/ mice express surface IgA, as predictedfrom the presence of CT-a andPST-a in sorted BMBcells.
A much smaller fraction of BM B cells from Aicda/ mice
stained with the IgA antibody (Figure 2D, bottom). IgA
staining in Aicda/mice is presumably due to some non-
specific binding by the anti-IgA reagent. To confirm that
the IgA staining of Aicda+/ B cells is specific, samples
were also stained with an isotype control antibody (Fig-
ure 2D, top). In contrast to the result with anti-IgA, thereImmunity 27, 64–75, July 2007 ª2007 Elsevier Inc. 67
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cells, Splenic Transitional B cells, or
Follicular B Cells by Cell Sorting for
Genomic DNA PCR
BM immature B cells (AA4.1+B220+k+l+) were
sorted as described in Figure S1A. Splenic
transitional B cells (transitional type 1 and 2)
and mature follicular B cells were sorted as
AA4.1+IgMhiIgD+ and AA4.1IgMloIgDhi, re-
spectively.was a very low frequency of staining of both Aicda+/ and
Aicda/ B cells with the isotype control antibody.
Figure 2E summarizes IgA surface staining of BM B cells
from a number of mice. The difference in the fraction of
IgA+ cells in Aicda+/ compared to Aicda/ mice was
reproducible (mean value of 3.91% versus 1.28%, respec-
tively) and statistically significant (p < 0.01).
To confirm that the cells identified as IgA+ by FACS are
the actively switching population, AA4.1+B220+IgA+ BM
cells were sorted and assayed for the presence of AID ex-
pression, PST-a, CT-a, and a-transcript. All thesemarkers
of CSR were detected in cells from Aicda+/ but not
Aicda/ mice (Figure 2F). We also confirmed by DNA se-
quence analyses that all a-transcripts exhibited functional
V-D-J-Ca recombinations (Figure S2).
Our data clearly demonstrate that ongoing, fully func-
tional CSR takes place during B cell development.
Active SHM in BM Immature B Cells and Further
Diversification in the Spleen of Normal Inbred Mice
The physiological function of AID expression and SHM
during B cell developmentmay be to contribute to Ig diver-
sification, by analogy with their role in Ig diversification
in sheep and cattle (Reynaud et al., 1995). If this is the
case, somatic variants should be found also in the spleen
of naive mice. We therefore looked at the frequency of
SHM in k light chains derived from the Vk4 light-chain
gene family of sorted immature BM B cells, splenic imma-
ture B cells (also called, transitional B cells), and splenic
naive mature follicular B cells. According to published re-
ports (Brekke and Garrard, 2004; Thiebe et al., 1999) all of
the mouse germline Vk light-chain genes have been se-
quenced and they consist of 140 germline genes, 93 of
which are functional with the remaining 47 being pseudo-
genes. These genes are distributed into 18 families of
germline Vk light-chain genes and the Vk4 family is the
largest, with 27 highly homologous functional genes and
6 pseudogenes. The database for Vk light-chain genes is68 Immunity 27, 64–75, July 2007 ª2007 Elsevier Inc.a composite of sequences from the C57BL/6, BALB/c,
A/J, 129, C3H, and DBA strains of mice. Comparison of
Vk light-chain genes from various inbred strains has led
to the conclusion that there are few or no polymorphisms
between most germline Vk light chain gene alleles from
different inbred strains (Thiebe et al., 1999).
To avoid detecting SHM in contaminating RNA from
plasma cells, plasmablasts, or preplasma memory cells,
we used PCR to amplify rearranged genomic DNA from
sorted populations. The PCR strategy is diagrammed in
Figure S3. The reverse primer was designed to anneal
on the 30 intronic region of the Jk5 exon, and therefore
the primers used will amplify rearranged Vk4-Jk5 seg-
ments of genomic DNA specifically. We reasoned that
this strategy might maximize our chances of detecting
SHM because autoreactive light-chain genes that used
Jk5 and are therefore unable to undergo further light-chain
rearrangements might use SHM as an alternative recep-
tor-editing mechanism. The frequency of clones express-
ing a particular germline Vk4 in these groups of mice were
quite similar (data not shown).
Immature B cells (B220+AA4.1+k+l+) were sorted from
BM as shown in Figure 3 and described in Figure S1. For
the purification of splenic transitional or follicular B cells,
lymphocytes were gated by side scatter (SSC) and for-
ward scatter (FSC), and dead cells were excluded by PI
staining. Viable lymphocytes were projected for AA4.1
surface expression to distinguish immature (AA4.1+) ver-
sus mature (AA4.1) splenic B cells. Among immature
splenic B cells, transitional type-I (T1: IgMhiIgDlo) and tran-
sitional type-2 (T2: IgMhiIgDhi) populations were combined
and sorted as transitional B cells (AA4.1+IgMhiIgD+). On
the other hand, among AA4.1 population that includes
mature B cells and non-B cells, surface IgMloIgDhi cells
were gated and sorted as naive mature follicular B cells
(AA4.1IgMloIgDhi) (Figure 3). Each compartment was
sorted from single-cell suspensions pooled from five
C57BL/6 mice. DNA sequencing analysis of the isolated
Immunity
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BM immature B cells (AA4.1+B220+k+l+), splenic transitional B cells (AA4.1+IgMhiIgD+), and follicular B cells (AA4.1IgMloIgDhi) were sorted as shown
in Figure 3. Rearranged Vk4-Jk5 light-chain DNA was amplified with a specific primer set (Figure S3), cloned, and sequenced.
(A) Analysis of sequences with mutations is depicted by pie charts. Numbers outside of each pie chart are the number of mutations/clone. The size of
the wedge is proportional to the percentage of clones carrying that number of mutations. Inside each inner circle is the number of clones sequenced.
Each p value was obtained by two-tailed Student’s t test.
(B) Mutation frequencies were calculated by the number of nt change per 104 bp from C57BL/6 (filled bars) and from Aicda/ (open bars) mice.Vk4 regions shows that the number of clones carrying
mutation(s) and the mutation frequency in AID-deficient
mice were at background levels: 4.4, 5.3, and 5.6 nt
changes per 104 bp from immature B, transitional B, and
follicular B cells, respectively (Figures 4A and 4B). In com-
parison, we isolated more clones of mutated Vk4-Jk5
genes from BM and splenic B cells of C57BL/6 mice
(Figure 4A). The mutation frequencies were 19, 20.5, and
39.7 nt changes per 104 bp in clones amplified from imma-
ture B, transitional B, and follicular B cells, respectively.
The gradual increase in the number of clones that carry
multiple mutations and the total frequency of nucleotide
change suggests that mutations accumulate as B cells
mature in the spleen (Figures 4A and 4B). Some examples
of somatic variant sequences by ClustalW analysis are
shown in Figure S4.
These results indicate that SHMcan be found not only in
BM immature B cells but also in naive splenic B cells. Also,
the mutations tend to be accumulated through the B cell
maturation process in unimmunized mice, supporting
the idea that AID-mediated SHM is a physiologically im-
portant diversification mechanism in the mouse preim-
mune repertoire.
Somatic Hypermutation in Developing B Cells
Is Not an Artifact by Contamination of Plasma Cells
B lymphocyte-induced maturation protein-1 (Blimp-1) is a
transcriptional repressor that is encoded by Prdm1 and
a ‘‘master regulator’’ for the formation of plasma cells
(Shapiro-Shelef et al., 2003). Mice lacking Prdm1 are early
embryonic lethal, and therefore, B cell-specific Blimp-1-
deficient mice (Prdm1flox/floxCd19Cre/+) had been gener-
ated by crossing Prdm1flox/flox mice with transgenic mice
that express Cre recombinase under the control of the
CD19 promoter (Cd19Cre/Cre). These mice had normal B
cell development but were defective in the formation ofIg-secreting plasma cells and preplasma memory B cells
(Shapiro-Shelef et al., 2003).
To address whether somatic variants that we found
from immature B cells are artifacts by contamination of
BM-residing plasma cells in a more definitive way, we
generated and examined B cell-specific Blimp-1-deficient
mice (Prdm1flox/floxCd19Cre/+, hereafter Prdm1/) as pre-
viously described (Shapiro-Shelef et al., 2003). An inter-
cross between F1 gave rise to Prdm1/ mice along
with wild-type littermate controls.
As previously described (Shapiro-Shelef et al., 2003),
naive Prdm1/ mice had extremely low serum IgM com-
pared to wild-type littermate controls (Figure 5A). Pre-B
and immature B cells from Prdm1/ and control mice
were sorted as described above. The staining profiles
from the two groups were indistinguishable (Figure S5A).
AID expression between Prdm1/ and wild-type devel-
oping B cells was determined by qPCR from sorted pre-
B and immature B cells. We did not find any statistically
significant difference between Prdm1/ mice and wild-
type littermate control in AID expression by this assay
(Figure 5B). Frequency of SHM in Vk4 was analyzed to
ensure that SHM takes place in developing B cells in the
absence of plasma cells or memory B cells. Indeed, com-
parable frequency of SHM was found between Blimp-1-
deficient and wild-type B cells (Figure 5C).
The results fromBlimp-1-deficient mice definitively indi-
cate that our observations of AID expression and SHM
in BM developing B cells are not artifacts of plasma cell
contamination.
AID Expression, CSR, and SHM in Developing
B Cells Are T Independent
To determine whether expression of AID and CSR in pre-B
and immature B cells were dependent on T cell help,
cDNAs from sorted developing B cells from athymicImmunity 27, 64–75, July 2007 ª2007 Elsevier Inc. 69
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SHM in Blimp-1-Deficient Developing B
Cells
(A) Sera from 6-week-old naive mice were
tested for IgM by ELISA to screen Prdm1/
and wild-type control mice.
(B) Pre-B and immature B cells were sorted
and relative AID expression was measured by
qPCR as described in Experimental Proce-
dures. One representative out of two similar re-
sults is shown. Error bars represent standard
deviation.
(C) SHM of the Vk4 light chain was analyzed via
cDNA generated from sorted immature B cells.
The mutation frequency was also calculated as
shown in the table. The p value was obtained
by two-tailed Student’s t test.nude (Foxn1nu/Foxn1nu) mice were analyzed for AID and
CT expression. These nude mice have a C57BL/6 genetic
background.
Nude mice showed normal pre-B and immature B cell-
surface marker profiles compared to the wild-type litter-
mate controls (Figure S5B). RAG-2 expression is shown
for pre-B and immature B cells from both nude mice and
the controls (Figure 6A). According to both PCR (Figure 6A)
and qPCR (Figure 6B) assays, AID expression levels in
pre-B and immature B cells from nude mice were similar
to those found in wild-type littermate controls. In addition,
CTs and PSTs for IgA and IgG2b were detected from pre-
B and immature B cells of both nude and the control mice,
clearly indicating that ongoing CSR takes place in devel-
oping B cells of both athymic nude and wild-type control
mice (Figure 6C). We also compared the frequency of
Vk4 variants in immature B cells from nude and wild-type
littermate control mice. We found very similar frequency
of Vk4 variants: 12.4 versus 13.2 nucleotide changes per
104 bp from nude and wild-type immature B cells, respec-
tively (Figure 6D). These results strongly support the idea
that AID expression, ongoing CSR, and active SHM are
T cell independent.
Signals via BCR and TLR Are Critical for AID
Expression in Developing B Cells In Vivo
To explore a possible role of TLR or BCR signaling in AID
expression during B cell development in vivo, we exam-
ined relative AIDmRNA expression of pre-B and immature
B cells in MyD88- and Bruton’s tyrosine kinase (Btk)-defi-70 Immunity 27, 64–75, July 2007 ª2007 Elsevier Inc.cient mice compared to their wild-type littermate controls.
Btk is a molecule that is important for signaling mediated
by BCR crosslinking (Rawlings et al., 1993; Thomas et al.,
1993). We also tested ‘‘triple D’’ (3D) mice, which are
homozygous for a recessive mutation of Unc93b1, gener-
ated by ENU (N-ethyl-N-nitrosurea) mutagenesis per-
formed on a pure C57BL/6 background. 3D mice are de-
fective in nucleic acid sensing through TLR3, TLR7, and
TLR9 and also impaired inMHCclass I and class II presen-
tation of exogenous antigens (Tabeta et al., 2006).
Btk/ mice showed a marked reduction in AID expres-
sion compared to the wild-type C57BL/6 background
(Figure 7A). Notably, AID expression in immature B cells
had a profound difference (about 90%decrease in relative
AID expression in immature B cells compared to those of
C57BL/6), whereas there was negligible difference found
in pre-B cells. It suggests that in immature B cell stages,
BCR crosslinking is the major signal to induce AID expres-
sion. Myd88/ (Figure 7B) and Unc93b13d/3d (Figure 7C)
mice also showed a significant (p < 0.01) decrease of AID
expression in pre-B and immature B cells compared to
their wild-type littermate controls. Interestingly, both
Myd88/ and Unc93b13d/3d mice displayed a significant
decrease in AID expression not only in immature B cells
but also in pre-B cells. For example, about 75% or 70%
decrease in AID expression (normalized by b-actin ex-
pression) was detected in pre-B cells whereas about 70%
or 60% decrease was found in immature B cells from
Myd88/ or Unc93b13d/3d, respectively, compared to
their wild-type controls. This finding suggests that in
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CSR in Athymic Nude Developing B Cells
(A) AID and RAG-2 expression were examined
by RT-PCR. No PP was found in nude mice.
(B) Relative AID expression from sorted pre-B
and immature B cells of nude and wild-type
control mice was measured by qPCR as de-
scribed in Experimental Procedures. One out
of three similar results is displayed. Error bars
represent standard deviation.
(C) CTs and PSTs for a and g2b were detected
from developing B cells of nude and wild-type
littermate controls. Composite results from
separate blots are presented for CTs. Loading
was not sufficiently normalized to allow quanti-
tative comparisons between samples.
(D) SHM of the Vk4 light chain was analyzed as
described in Figure 5C.pre-B cells where light-chain rearrangement of BCR is not
complete, TLR-mediated signals, and especially signals
initiated by nucleic acids, may play a dominant role in
AID expression. However, it is noteworthy that we did not
see a complete shut-down of AID expression in Btk/,
Myd88/, or Unc93b13d/3d, indicating that stimuli other
than BCR crosslinking or TLR signaling can contribute to
induce AID expression in developing B cells.
DISCUSSION
B cell antigen receptor (BCR) diversification in early
mouse BM B cells is known to involve combinatorial
gene rearrangements mediated by V(D)J recombination
mechanisms. We have now found that V(D)J rearrange-
ment is not the only mechanism for BCR diversification
in early mouse B cells. Our results show that the AID is ex-
pressed in BM pre-B and immature B cells of normal wild-
type mice. AID expression in these cells leads to active
CSR and SHM as part of the normal, T cell-independent,
developmental program. AID expression in developing B
cells differs between various mouse strains; these differ-
ences suggest genetic factors that affect the level and
timing of AID expression in various B cell stages. BCR
and TLR are involved in the expression of AID in early B
cells, suggesting that signaling through these receptors
is important for the induction of AID expression.
It is important to note that several observations indicate
that small numbers of BM-residing plasma or memory B
cells cannot account for our findings of AID expression
in early B cells. First, plasma cells are substantially larger
than developing B cells and are gated out of our earlyB cell populations by size. Second, our developing B cell
populations are AA4.1+B220+ but BM plasma cells do
not express surface AA4.1 or B220 (Kallies et al., 2004;
McKearn et al., 1984). Third, Blimp-1 is amaster transcrip-
tion factor that is required for formation and maintenance
of long-lived plasma cells and preplasma memory B cells
in BM (Shapiro-Shelef et al., 2003, 2005). Yet, high Blimp-
1 expression is restricted to rare cells in lymphoid tissues
(from 0.1% to 0.5%) and suppress the expression of
both B220 and AID (Kallies et al., 2004), indicating that
plasma or memory B cells are unlikely to be present in
our AA4.1+B220+AID+ populations. Fourth, comparable
AIDmRNA expression and ongoing CSR are found in early
B cells from nude and wild-type littermate controls mice
even though nude mice lack GC reactions, plasma cells,
or memory B cell formation. Finally, B cell-specific
Blimp-1-deficient mice that lack plasma cells show no
substantial differences in AID expression in both pre-B
and immature B cells when compared to wild-type litter-
mates (Figure 5). Taken together, these considerations
provide compelling evidence against any significant con-
tamination of mature B cells in our BM-derived pre-B
and immature B cell populations.
A recent study that used mutant mice carrying reporter
gene constructs designed to detect AID-expressing cells
by flow cytometric analysis shows no AID reporter expres-
sion in bone-marrow cells in vivo even though detectable
AID expression could be found by real-time PCR analysis
(Crouch et al., 2007). However, we find clear AID expres-
sion and AID function in developing bone-marrow B cells,
suggesting that the reporter construct analysesmay be in-
sufficiently sensitive to detect low AID expression evenImmunity 27, 64–75, July 2007 ª2007 Elsevier Inc. 71
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manuscript was under review, Kelsoe and colleagues re-
ported that AID is expressed in mouse developing B cells
in vivo and that splenic immature (or transitional) B cells,
when stimulated in culture through TLR engagement,
can switch isotypes and differentiate to plasma cells
in vitro (Ueda et al., 2007). Our results extend Kelsoe’s
findings to B cells maturing in the intact animal by clearly
demonstrating that developing B cells in both the bone
marrow and spleen actively undergo in vivo CSR and
SHM by TLR and BCR engagement. Our results indicating
Figure 7. Decreased AID Expression in Developing B Cells of
Btk/, Myd88/, and Unc93b13d/3d Mice
Relative AID expression in pre-B and immature B cells from (A) Btk/,
(B) Myd88/, and (C) Unc93b13d/3d (3D) mice were measured by
qPCR from the sorted cells. C57BL/6 (A and C) of the same age and
(B) the wild-type littermates (Myd88+/+) were used as controls. Both
(A) and (B) are one representative out of three experiments and (C)
was done once. Each p value was obtained by two-tailed Student’s
t test. Error bars represent standard deviation.72 Immunity 27, 64–75, July 2007 ª2007 Elsevier Inc.that active CSR can occur in early developing mouse B
cells alter the prevailing paradigm of CSR limited to ma-
ture B cells stimulated in the periphery and usually in
GCs. Our findings could also account for the unexpected
CSR that has been found in mutant mice (mMT mice) that
cannot producemembrane-bound m chains. The mMTmu-
tant mice have a pro-B cell developmental block resulting
in a lack of peripheral B cells with surface IgM (Kitamura
et al., 1991). Despite this defect in B cell development,
mMTmice have been found to have normal titers of serum
IgA (in a C57BL/6 background) (Macpherson et al., 2001)
or serum IgG and IgA (in a BALB/c background) (Orinska
et al., 2002; Hasan et al., 2002). The ability of pre-B cells
to undergo CSR, and thereby produce membrane-bound
IgG or IgA to circumvent the pro-B block, would provide
a straightforward explanation for IgG and IgA expression
in the mMT mice. The differential Ig isotype expression
in C57BL/6 and BALB/c mMT mice could reflect genetic
differences affecting CSR in these mouse strains; this is
reminiscent of the genetic background effects we find
for CSR in pre-B and immature B cells in normal mice.
For both normal and mMT mice, culturing B220+ BM
cells in vitro with IL-7 has been reported to lead to AID
expression, IgG germline transcription, and the detection
of PSTs (Seagal et al., 2003). These results are consistent
with our findings of AID expression and CSR even in
unstimulated BM early B cells. However, because mMT-
Faslpr/lpr mice showed an increase in the production of
IgG-producing B cells in these in vitro cultures, it has
been suggested that IgG-positive B cells developing in
the BM in vivo are deleted by a Fas-FasL-mediated path-
way (Seagal et al., 2003). However, mMT mice exhibit
nearly normal titers of serum IgG and IgA, indicating that,
in vivo, IgG- and IgA-expressing BMB cells are not neces-
sarily deleted even in the presence of an intact Fas-FasL
pathway. Rather, CSR in the early stages of in vivo B cell
development might provide a protective mechanism for
young, preimmune animals by generating IgG- or IgA-pro-
ducing cells. As suggested previously, CSR at the pre-B
cell stage could also represent an alternative backup
pathway for B cell development (Macpherson et al., 2001).
Abelson murine leukemia virus (Ab-MuLV) infection of
mouse BM cells can lead to establishment of transformed
tumor cell lines that have a pre-B cell phenotype (Burrows
et al., 1981; DePinho et al., 1984; Sugiyama et al., 1986).
Some of these pre-B cell lines exhibit CSR of g2b or g3
heavy-chain constant region genes, discordant with the
notion that CSR is limited tomature B cells. These findings
have generally been ascribed to inappropriate CSR regu-
lation in these transformed cell lines. Our demonstration of
CSR in normal pre-B cells could explain the active CSR
found in Ab-transformed pre-B cell lines, but a recent re-
port showing that Ab-MuLV infection of BM pre-B cells
can greatly enhance AID expression provides an alternate
mechanism to account for CSR in these cell lines (Gourzi
et al., 2006). Interestingly, Ab-MuLV induction of AID in in-
fected pre-B cells inhibits tumorigenicity, and it has been
suggested that AID-induced DNA damage, leading to de-
creased proliferation and increased NK cell targeting,
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would appear that such effects of AID expression on pro-
liferation and NK cell targeting are limited to virus-infected
cells because (1) normal mature B cells proliferate and ex-
pand greatly after stimulations that induce AID expression
and CSR (Muramatsu et al., 2000), and (2) as our results
indicate, AID-expressing BM pre-B cells in normal mice
appear to differentiate normally into immature B cells
that express AID at higher levels. Thus, AID expression
appears to play at least two roles in early B cells: induction
in virally infected pre-B cells leading to inhibition of the
tumorigenicity of these infected cells, and induction in nor-
mal early B cells to provide receptor diversification during
B cell development.
AID expression in immature B cells also mediates SHM.
A previous report had shown AID expression, but no SHM
of l light chain, in immature B cells from wild-type C57BL/
6 mice (Mao et al., 2004). We now find that AID expression
can, in normal mice, lead to SHM of Vk4 in the BM pre-B
and immature B cells. We do not know why SHM was not
detected previously in l light chain of C57BL/6 mice, but
this could reflect a lower SHM frequency in l relative to
Vk4 or might be due to a process that selectively amplifies
early B cells carrying mutations in Vk4 (see below).
What roles might SHM be playing in early B cells? Obvi-
ously thismechanism could provide additional preimmune
repertoire diversity in mature B cells to supplement the di-
versity from V(D)J recombination. AID expression in early
B cells could also be involved in receptor editing of self-
reactive BCR that used SHM as a mechanism. Previous
studies have indicated that B cells expressing rearranged
Vk4 genes are frequently negatively selected, perhaps be-
cause they are autoreactive (Kalled and Brodeur, 1990).
We propose that the Vk4 hypermutation that we have de-
tected in immature B cells might be linked to receptor ed-
iting during thematuration of these cells. TLR dependency
of AID expression during B cell development could be
related to this hypothesis. In mature B cells, synergistic
engagement of TLR and BCR can activate quiescent or
autoreactive B cells in vitro (Leadbetter et al., 2002), and
we suggest that autoreactive developing B cells can be
activated by the same synergistic engagement of TLR
and BCR. Thus, expression of AID during B cell develop-
ment could both provide Ig diversity and serve as an addi-
tional mechanism of receptor editing in autoreactive
B cells.
When SHC, which is known to also require AID, was first
found in immature B cells in the chicken bursa (Reynaud
et al., 1987), it was a notable deviation from B cell diversi-
fication by V(D)J recombination in the bone marrow of
mice and humans. However, our results, showing AID-
mediated Ig diversification in the mouse bone marrow,
suggest that AID expression and function are a part of
the normal early B cell developmental program in mice,
as in chickens, sheep, and other species (Cooper, 2002).
Our findings lessen the appearance of evolutionary differ-
ences in B cell development between these species.
In this report, we have demonstrated the expression of
fully functional AID in developing B cells of normal mice.Early B cell AID expression, CSR, and SHM are induced
in a T-independent manner as a part of the normal B cell
developmental process. The induction of AID, CSR, and
SHM in developing B cells was BCR and TLR dependent,
suggesting that recognition of self-antigens by synergistic
engagement of BCR and TLRs is the major mechanism of
this process. Our findings provide evidence that the innate
immune system plays an important role in shaping adap-
tive immunity at early stages of lymphocyte development.
EXPERIMENTAL PROCEDURES
Mice
All experiments with mice were performed in accordance with the
regulations and with the approval of Tufts/NEMC IACUC. C57BL/6,
CBA, Cd19Cre/Cre (Cd19tm1(cre)Cgn), B6.Cg-Foxn1 (nude mice), and
littermate controls of nude mice were purchased from the Jackson
Laboratory. AID-deficient mice were obtained from J. Stavnezer (Uni-
versity of Massachusetts Medical School, Worcester, MA) with per-
mission from T. Honjo (Kyoto University, Kyoto, Japan), and the colony
is maintained in our facility. Myd88/ mice and wild-type littermate
controls were obtained from A. Marshak-Rothstein (Boston University
School of Medicine, Boston, MA) and L. Hu (Tufts-New England Med-
ical Center, Boston, MA). Unc93b13d/3d mice were provided by A.
Marshak-Rothstein. Btk/ and BALB/c mice were provided by H.
Wortis and N. Rosenberg (both in Tufts University School of Medicine,
Boston, MA), respectively. Permission to use the Btk/ mice was
kindly given by R. Hendricks (Erasmus University Medical Center, Rot-
terdan, The Netherlands). All mice were maintained in a pathogen-free
mouse facility of Tufts University School of Medicine.
Flow Cytometry and Cell Sorting
Cells were stained for flow cytometry via standard procedures. Propi-
dium iodide (PI) was added just prior to sorting on a MoFlo instrument
(Dako Cytomation), and FACS analysis was done with FACSCalibur
(BD Biosciences). Detailed staining procedures are described in
Supplemental Data.
Genomic DNA Purification, RNA Purification, and Generation
of First-Strand cDNA
Genomic DNAwas prepared by AquaPure Genomic DNA Kit (Bio-Rad)
or by DNeasy Tissue Kit (QIAGEN) according to the manufacturer’s
instruction. Cells were lysed in TRIzol reagent (Invitrogen) to purify
RNA. First strand of the cDNA was synthesized in a 20 ml reaction
with oligo(dT)20 and SuperScript III (Invitrogen) according to the man-
ufacturer’s instruction.
PCR
For AID, RAG-2, CT, PST, and GAPDH, 2 ml of the first-strand cDNA
was amplified in a 20 ml reaction by Platinum Taq DNA Polymerase
(Invitrogen). Oligonucleotide primers and conditions for PCR are de-
scribed in Supplemental Data.
Cloning and Sequencing
Detailed information for oligonucleotide primers and conditions for
amplification of rearranged Vk4 is described in Supplemental Data.
In brief, Platinum Taq DNA polymerase High Fidelity (Invitrogen) was
used. Amplified Vk4 products were cloned into pCRII-TOPO vector
(Invitrogen). Plasmid DNAs were purified with QIAprep Spin Miniprep
Kit (QIAGEN), and the PCR products were sequenced at Tufts Univer-
sity Core Facility (Tufts University School of Medicine, Boston, MA) or
at Genewiz Inc. (Plainfield, NJ).
Quantitative Real-Time PCR
All qPCR experiments were carried out and analyzed as follows: first-
strand cDNA synthesis was performed on 4-fold serial dilutions ofImmunity 27, 64–75, July 2007 ª2007 Elsevier Inc. 73
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TLR- and BCR-Mediated CSR and SHM in Early B Cellspurified RNA. Triplicate for each cDNA reaction was used for amplifica-
tion with a predesigned mouse AID- or b-actin (endogenous control)-
specific TaqMan primer/probe set (Applied Biosystems) in an ABI
PRISM 5700 Sequence Detection System (Applied Biosystems). Rela-
tive quantification was determined after establishing standard curves
for mouse AID and b-actin expression. qPCR data represent means
that were obtained from triplicates of each 4-fold dilution of first-strand
cDNA reaction ± SD.
Southern Blot Analysis
PCR products of CT were separated with 2% agarose gel electropho-
resis, transferred to Zeta-Probe Blotting Membranes (Bio-Rad). Oligo-
nucleotide probe for Cmwas end-labeledwith [g-32P]ATP as previously
described (Kinoshita et al., 2001). The labeled probe was purified by
NucAway Spin Columns (Ambion) before hybridization.
Supplemental Data
Five figures and Experimental Procedures are available at http://www.
immunity.com/cgi/content/full/27/1/64/DC1/.
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